Buy Keytruda 100mg/4ml-EU Pembrolizumab

Keytruda 100mg/4ml-EU (Pembrolizumab) is an injectable prescription medication used in oncology. This single-use vial contains 100mg of pembrolizumab in 4ml solution, stored at 2-8°C. Pembrolizumab is a humanized monoclonal antibody indicated for certain cancers. Suitable for patients seeking targeted immunotherapy options.

Strength

100mg/4ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Merck Sharp & Dohme Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Pembrolizumab is a prescription immunotherapy used to treat various cancers by helping the immune system recognize and attack cancer cells. It is commonly used for melanoma, lung cancer, and other solid tumors when prescribed by a healthcare provider. Patients often ask, 'what is pembrolizumab used for' to understand its role in cancer treatment. This medication is part of a broader category of cancer therapies designed to target specific pathways in tumor growth.

Side Effects

Pembrolizumab works by blocking a protein called PD-1, which can help the immune system respond more effectively to cancer cells. Patients may experience immune-related side effects as the body’s immune response is enhanced. Common effects include fatigue, skin reactions, or gastrointestinal symptoms, though these vary by individual. The medication’s effects are typically monitored by a healthcare professional during treatment.

Precautions & Warnings

Pembrolizumab should be handled and administered by a healthcare professional in a clinical setting. It is stored refrigerated at 2-8°C and protected from light. Patients should inform their doctor of all medications and medical conditions before starting treatment. Regular monitoring is required to manage potential immune-related side effects.

Avoid Interactions

Pembrolizumab may interact with other medications that affect the immune system, such as corticosteroids or immunosuppressants. Patients should avoid live vaccines while on treatment unless approved by their doctor. Alcohol and certain over-the-counter medications may also interact, so full disclosure of all substances is advised. Always consult a healthcare provider before combining therapies.

References

Frequently Asked Questions

Pembrolizumab is used to treat certain types of cancer by helping the immune system target cancer cells.

It is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects may include fatigue, skin reactions, or gastrointestinal symptoms, but these vary by individual.

No, pembrolizumab should be stored refrigerated at 2-8°C and protected from light.

Yes, it may interact with immunosuppressants, corticosteroids, or live vaccines; consult your doctor.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.